Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ gM;}#>6
NCA{H^CL
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© VS?@y/\In
vd#,DU=p!
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?3sT"r_d@
BH0!6Oq
1.Co-stimulators (or co-stimulating molecules) {gf>*
aI#4H+/
2.NK-kB Mj0Cat=
^6 /j_G
3.Immunoglobulin superfamily j~ym<-[{a
yYAnwf
4.antigen-presenting cell (APC) zjbE 7^N
AvRcS]@=
5.death domain 3_qdJ<,
4E"d /
6.CCR and CXCR {V2bU}5
[
:B#EqeI
7.Lectin (or mitogen) }X1.Wt=?
2tr
:xi@
8.Clusters of differentiation, CD) LZWS^77
!y vJpdsof
9.B7 family q
@ Kk\m
7u%a/ <
10.Cytotoxic T lymphocyte, CTL) ~"mj;5Id
S!j^|!
11.IL-15 and IL-15 receptor (IL-15R) 4: sl(r
(L#%!bd
12.MHC restriction 7Jx%JgF
\REc8nsLy
13.Affinity-chromatography }K8Lm-.=
{'IFWD. 5
14.Cyctosprin A, CsA npj/7nZj
x YT}>#[
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) +Jw{qQR/*
``-k{C#F
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© aY j%w
*]!l%Uf%
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 _<u;4RO(s
6$z'wy/*
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 0ny{)Sd6um
G;2[
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ %]GV+!3S
$nFAu}%C
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ;Id"n7W
V2QW\2@$
ÃâÒßѧרҵ£º /hfUPO5
>t,O2~
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ r]-+bR
vrO%XvXW
Ïû»¯ÄÚ¿Æ£º @SQceQfB
Fv
a]
*5
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 9F)W19i.
/1N)d?Pcl
ѪҺ²¡Ñ§×¨Òµ£º }JGq 1
K
/ZHJkJ7
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿